We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+27.43%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.73B
AUM Growth
+$371M
Cap. Flow
-$511M
Cap. Flow %
-10.8%
Top 10 Hldgs %
7.01%
Holding
1,405
New
92
Increased
215
Reduced
417
Closed
102

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$19.8M
2
CL icon
Colgate-Palmolive
CL
+$18.1M
3
FOXA icon
Fox Class A
FOXA
+$17.4M
4
WRK
WestRock Company
WRK
+$17M
5
ROL icon
Rollins
ROL
+$17M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$27.9M
2
AMGN icon
Amgen
AMGN
+$25.5M
3
PFE icon
Pfizer
PFE
+$24.6M
4
WM icon
Waste Management
WM
+$23.8M
5
SUI icon
Sun Communities
SUI
+$22.3M

Sector Composition

Rank Sector Weight
1 Financials 23.79%
2 Technology 12.1%
3 Industrials 11.16%
4 Healthcare 10.96%
5 Consumer Discretionary 10.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FSBW icon
1326
FS Bancorp
FSBW
$320M
– –
-24,600
Closed -$504K
GTY
1327
Getty Realty Corp
GTY
$2.07B
– –
-10,400
Closed -$271K
HNRG icon
1328
Hallador Energy
HNRG
$696M
– –
-195,600
Closed -$128K
HRZN icon
1329
Horizon Technology Finance
HRZN
$311M
– –
-24,900
Closed -$306K
HST icon
1330
Host Hotels & Resorts
HST
$16B
– –
-1,142,100
Closed -$12.3M
HTH icon
1331
Hilltop Holdings
HTH
$2.24B
– –
-102,700
Closed -$2.11M
HUBG icon
1332
HUB Group
HUBG
$2.92B
– –
-345,200
Closed -$8.66M
IBRX icon
1333
ImmunityBio
IBRX
$8.1B
– –
-13,300
Closed -$92K
IDYA icon
1334
IDEAYA Biosciences
IDYA
$3.56B
– –
-45,000
Closed -$565K
INVE icon
1335
Identive
INVE
$61.9M
– –
-18,500
Closed -$116K
ITW icon
1336
Illinois Tool Works
ITW
$84.5B
– –
-10,160
Closed -$1.96M
KRMD icon
1337
KORU Medical Systems
KRMD
$164M
– –
-14,000
Closed -$101K
KRNY icon
1338
Kearny Financial
KRNY
$599M
– –
-22,818
Closed -$165K
MZTI
1339
The Marzetti Company
MZTI
$3.11B
– –
-1,900
Closed -$340K
LFCR icon
1340
Lifecore Biomedical
LFCR
$190M
– –
-15,000
Closed -$146K
LFVN icon
1341
LifeVantage
LFVN
$85.3M
– –
-37,100
Closed -$448K
LGIH icon
1342
LGI Homes
LGIH
$1.4B
– –
-2,300
Closed -$267K
LMT icon
1343
Lockheed Martin
LMT
$136B
– –
-4,920
Closed -$1.89M
LRMR icon
1344
Larimar Therapeutics
LRMR
$432M
– –
-10,250
Closed -$155K
LVS icon
1345
Las Vegas Sands
LVS
$29.6B
– –
-37,600
Closed -$1.75M
MATX icon
1346
Matsons
MATX
$6.18B
– –
-71,990
Closed -$2.89M
MBIN icon
1347
Merchants Bancorp
MBIN
$2.49B
– –
-133,650
Closed -$1.76M
MRTN icon
1348
Marten Transport
MRTN
$1.22B
– –
-324,955
Closed -$5.3M
MU icon
1349
Micron Technology
MU
$991B
– –
-594,570
Closed -$27.9M
NATR icon
1350
Nature's Sunshine
NATR
$288M
– –
-26,000
Closed -$301K
52 53
54
55 56

Similar funds

SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return

Bridgeway Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Bridgeway Capital Management held 1,405 positions worth $4.73B, up 8.5% from $4.36B the previous quarter. Its ten largest holdings account for 7% of the portfolio.

Bridgeway Capital Management withdrew a net $511M in Q4 2020, closing 102 positions and reducing 417 holdings. Its most notable exit was Micron Technology, an estimated $27.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.

Against the trend, Bridgeway Capital Management opened a new position in Abbott worth $19.9M.

  • Bridgeway Capital Management's largest Q4 2020 buy was Abbott: 182,150 shares worth $19.9M.
  • Bridgeway Capital Management added most to Rollins in Q4 2020, an estimated $17M increase.
  • Bridgeway Capital Management's biggest Q4 2020 reduction was Pfizer, cutting an estimated $24.6M.
  • Bridgeway Capital Management fully exited Micron Technology in Q4 2020, selling an estimated $27.9M.
  • Bridgeway Capital Management's ten largest holdings make up 7% of its $4.73B portfolio in Q4 2020.
  • Bridgeway Capital Management opened 92 new positions and closed 102 in Q4 2020.
  • Bridgeway Capital Management's portfolio value rose 8.5% quarter-over-quarter to $4.73B.

Based on Bridgeway Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.